Copyright Reports & Markets. All rights reserved.

Global HIV Drugs Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 HIV Drugs Market Overview

      • 1.1 Product Overview and Scope of HIV Drugs
      • 1.2 HIV Drugs Segment by Type
        • 1.2.1 Global HIV Drugs Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Multi-Class Combination Products
        • 1.2.3 Nucleoside Reverse Transcriptase Inhibitors
        • 1.2.4 Non-Nucleoside Reverse Transcriptase Inhibitors
        • 1.2.5 Protease Inhibitors
        • 1.2.6 Fusion Inhibitors
        • 1.2.7 Entry Inhibitors - CCR5 Co-Receptor Antagonist
        • 1.2.8 HIV Integrase Strand Transfer Inhibitors
      • 1.3 HIV Drugs Segment by Application
        • 1.3.1 HIV Drugs Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospital Pharmacies
        • 1.3.3 Retail Pharmacies
        • 1.3.4 Online Pharmacies
        • 1.3.5 Others
      • 1.4 Global HIV Drugs Market by Region
        • 1.4.1 Global HIV Drugs Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global HIV Drugs Market Size
        • 1.5.1 Global HIV Drugs Revenue (2014-2025)
        • 1.5.2 Global HIV Drugs Production (2014-2025)

      2 Global HIV Drugs Market Competition by Manufacturers

      • 2.1 Global HIV Drugs Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global HIV Drugs Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global HIV Drugs Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers HIV Drugs Production Sites, Area Served, Product Types
      • 2.5 HIV Drugs Market Competitive Situation and Trends
        • 2.5.1 HIV Drugs Market Concentration Rate
        • 2.5.2 HIV Drugs Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global HIV Drugs Production Market Share by Regions

      • 3.1 Global HIV Drugs Production Market Share by Regions
      • 3.2 Global HIV Drugs Revenue Market Share by Regions (2014-2019)
      • 3.3 Global HIV Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America HIV Drugs Production
        • 3.4.1 North America HIV Drugs Production Growth Rate (2014-2019)
        • 3.4.2 North America HIV Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe HIV Drugs Production
        • 3.5.1 Europe HIV Drugs Production Growth Rate (2014-2019)
        • 3.5.2 Europe HIV Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China HIV Drugs Production (2014-2019)
        • 3.6.1 China HIV Drugs Production Growth Rate (2014-2019)
        • 3.6.2 China HIV Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan HIV Drugs Production (2014-2019)
        • 3.7.1 Japan HIV Drugs Production Growth Rate (2014-2019)
        • 3.7.2 Japan HIV Drugs Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global HIV Drugs Consumption by Regions

      • 4.1 Global HIV Drugs Consumption by Regions
      • 4.2 North America HIV Drugs Consumption (2014-2019)
      • 4.3 Europe HIV Drugs Consumption (2014-2019)
      • 4.4 China HIV Drugs Consumption (2014-2019)
      • 4.5 Japan HIV Drugs Consumption (2014-2019)

      5 Global HIV Drugs Production, Revenue, Price Trend by Type

      • 5.1 Global HIV Drugs Production Market Share by Type (2014-2019)
      • 5.2 Global HIV Drugs Revenue Market Share by Type (2014-2019)
      • 5.3 Global HIV Drugs Price by Type (2014-2019)
      • 5.4 Global HIV Drugs Production Growth by Type (2014-2019)

      6 Global HIV Drugs Market Analysis by Applications

      • 6.1 Global HIV Drugs Consumption Market Share by Application (2014-2019)
      • 6.2 Global HIV Drugs Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in HIV Drugs Business

      • 7.1 Bristol-Myers Squibb
        • 7.1.1 Bristol-Myers Squibb HIV Drugs Production Sites and Area Served
        • 7.1.2 HIV Drugs Product Introduction, Application and Specification
        • 7.1.3 Bristol-Myers Squibb HIV Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Gilead Sciences
        • 7.2.1 Gilead Sciences HIV Drugs Production Sites and Area Served
        • 7.2.2 HIV Drugs Product Introduction, Application and Specification
        • 7.2.3 Gilead Sciences HIV Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 GlaxoSmithKline
        • 7.3.1 GlaxoSmithKline HIV Drugs Production Sites and Area Served
        • 7.3.2 HIV Drugs Product Introduction, Application and Specification
        • 7.3.3 GlaxoSmithKline HIV Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Johnson & Johnson
        • 7.4.1 Johnson & Johnson HIV Drugs Production Sites and Area Served
        • 7.4.2 HIV Drugs Product Introduction, Application and Specification
        • 7.4.3 Johnson & Johnson HIV Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Merck
        • 7.5.1 Merck HIV Drugs Production Sites and Area Served
        • 7.5.2 HIV Drugs Product Introduction, Application and Specification
        • 7.5.3 Merck HIV Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served

      8 HIV Drugs Manufacturing Cost Analysis

      • 8.1 HIV Drugs Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of HIV Drugs
      • 8.4 HIV Drugs Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 HIV Drugs Distributors List
      • 9.3 HIV Drugs Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global HIV Drugs Market Forecast

      • 11.1 Global HIV Drugs Production, Revenue Forecast
        • 11.1.1 Global HIV Drugs Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global HIV Drugs Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global HIV Drugs Price and Trend Forecast (2019-2025)
      • 11.2 Global HIV Drugs Production Forecast by Regions (2019-2025)
        • 11.2.1 North America HIV Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe HIV Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.3 China HIV Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan HIV Drugs Production, Revenue Forecast (2019-2025)
      • 11.3 Global HIV Drugs Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America HIV Drugs Consumption Forecast (2019-2025)
        • 11.3.2 Europe HIV Drugs Consumption Forecast (2019-2025)
        • 11.3.3 China HIV Drugs Consumption Forecast (2019-2025)
        • 11.3.4 Japan HIV Drugs Consumption Forecast (2019-2025)
      • 11.4 Global HIV Drugs Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global HIV Drugs Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        HIV is a type of retrovirus that causes serious complications in humans. It generally spreads via the blood, semen, vaginal fluid, pre-ejaculate, or breast milk. The global market for HIV drugs is envisaged to surpass USD 19,000 million by 2019 owing to the recent rise in HIV patient population.
        One of the primary factors catalyzing the growth of the global HIV drugs market is increase in the prevalence of HIV and its diagnosis. Apart from this, the market is also influenced by a rise in the number of government initiatives for spreading the awareness amongst people regarding causes, symptoms and treatments. Moreover, the introduction of generic drugs, which are cost-effective and chemically identical to branded drugs, act as another factor that is contributing towards the demand for HIV drugs.

        The global HIV Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on HIV Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall HIV Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Bristol-Myers Squibb
        Gilead Sciences
        GlaxoSmithKline
        Johnson & Johnson
        Merck
        ...

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Multi-Class Combination Products
        Nucleoside Reverse Transcriptase Inhibitors
        Non-Nucleoside Reverse Transcriptase Inhibitors
        Protease Inhibitors
        Fusion Inhibitors
        Entry Inhibitors - CCR5 Co-Receptor Antagonist
        HIV Integrase Strand Transfer Inhibitors

        Segment by Application
        Hospital Pharmacies
        Retail Pharmacies
        Online Pharmacies
        Others

        Buy now